Martin Diggle MA (Oxon)
Martin is a founder of Vulpes Investment Management, a Cayman Fund Manager which currently manages five funds including the Vulpes Life Sciences Fund, Chronos Therapeutics’ largest shareholder. [...]
Dr. Michael Moore PhD, DSc, FRCPath
Dr Michael Moore pursued an academic research career in a major UK cancer centre prior to entering the Life Sciences industry. He holds PhD and DSc degrees from the University of Nottingham and [...]
Dr Shawn Manning D.Phil (Oxon), BSC (Hons), ARCS
Shawn Manning has over 30 years of international Life Sciences experience, as a specialist independent advisor, equity analyst and broker, supporting a broad range of Life Science companies. He [...]
